Lechowicz, Mary Jo
Smith, Christy
Ristuccia, Robert
Dwyer, Karen
Funding for this research was provided by:
Kyowa Kirin Pharmaceutical Development
Article History
Received: 8 August 2023
Revised: 22 February 2024
Accepted: 6 March 2024
First Online: 27 March 2024
Declarations
:
: <b>ML</b> reports consulting fees from Secura Bio, EUSA Pharma, and Kyowa Kirin, and travel support from Secura Bio. <b>CS</b>, <b>RR,</b> and <b>KD</b> are employees of Kyowa Kirin.